2666-3341

F&S Reports

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 616 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact616 DOIs
2

Attach ORCID iDs across 172 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact172 DOIs
3

Deposit reference lists for 31 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact31 DOIs

DOIs for this ISSN

Showing the top 5 of 616 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Use of contraception among reproductive-aged women in the Un… (10.1016/j.xfre.2020.06.006)
Abstract ORCID
88.91 59
2 SARS-CoV-2 spike protein seropositivity from vaccination or… (10.1016/j.xfre.2021.05.010)
Abstract ORCID
82.17 43
3 Nonhormonal therapy for endometriosis: a randomized, placebo… (10.1016/j.xfre.2021.07.003)
Abstract ORCID
66.11 20
4 Embryo cryopreservation and utilization in the United States… (10.1016/j.xfre.2020.05.010)
Abstract ORCID
65.05 19
5 Oocyte cryopreservation in a transgender man on long-term te… (10.1016/j.xfre.2021.02.006)
Abstract ORCID
65.05 19
6 Isn’t it time to stop calling preimplantation embryos “mosai… (10.1016/j.xfre.2020.10.009)
Abstract ORCID
60.21 15
7 Knowledge gaps in the understanding of fertility among non-m… (10.1016/j.xfre.2020.08.002)
Abstract ORCID
55.70 12
8 Development of relugolix combination therapy as a medical tr… (10.1016/j.xfre.2022.11.010)
Abstract ORCID
55.70 12
9 Comparison of electronic versus manual witnessing of procedu… (10.1016/j.xfre.2021.04.006)
Abstract ORCID
53.96 11
10 Pregnancy success rates for lesbian women undergoing intraut… (10.1016/j.xfre.2021.04.007)
Abstract ORCID
53.96 11
11 Productivity loss due to polycystic ovary syndrome and its r… (10.1016/j.xfre.2024.02.004)
Abstract ORCID
53.96 11
12 Scope of practice distinctions based on primary work setting… (10.1016/j.xfre.2020.12.001)
Abstract References ORCID
52.42 4
13 Effect of vitamin E administered to men in infertile couples… (10.1016/j.xfre.2020.09.006)
Abstract ORCID
50.00 9
14 Employee benefit or occupational hazard? How employer covera… (10.1016/j.xfre.2020.09.007)
Abstract ORCID
50.00 9
15 Comparison of metabolic syndrome elements in White and Asian… (10.1016/j.xfre.2020.09.008)
Abstract ORCID
50.00 9
16 Efficacy and safety of elagolix with add-back therapy in wom… (10.1016/j.xfre.2021.05.004)
Abstract ORCID
50.00 9
17 Making it (net)work: a social network analysis of “fertility… (10.1016/j.xfre.2021.08.005)
Abstract ORCID
50.00 9
18 Impact of paternal age on embryology and pregnancy outcomes… (10.1016/j.xfre.2020.06.004)
Abstract ORCID
47.71 8
19 Lawsuit frequency and claims basis over lost, damaged, and d… (10.1016/j.xfre.2020.06.007)
Abstract ORCID
47.71 8
20 Pulsatile gonadotropin-releasing hormone: clinical applicati… (10.1016/j.xfre.2023.01.007)
Abstract ORCID
47.71 8
21 Assessing the impact of semen quality on embryo development… (10.1016/j.xfre.2020.10.012)
Abstract ORCID
45.15 7
22 Case report: two cases of mature oocytes found in prepuberta… (10.1016/j.xfre.2021.03.007)
Abstract ORCID
45.15 7
23 Traits of patients seen via telemedicine versus in person fo… (10.1016/j.xfre.2021.04.001)
Abstract ORCID
45.15 7
24 Dual trigger protocol is an effective in vitro fertilization… (10.1016/j.xfre.2021.05.008)
Abstract ORCID
45.15 7
25 Public attitudes in the United States toward insurance cover… (10.1016/j.xfre.2021.09.002)
Abstract ORCID
45.15 7
26 The association of euploid miscarriage with obesity (10.1016/j.xfre.2020.05.011)
Abstract ORCID
42.25 6
27 The efficacy of medical management of leiomyoma-associated h… (10.1016/j.xfre.2023.10.003)
Abstract ORCID
42.25 6
28 Disparities in access to fertility care: who’s in and who’s… (10.1016/j.xfre.2020.11.001)
Abstract
40.05 39
29 Underutilization of primary medical care among men presentin… (10.1016/j.xfre.2020.04.001)
Abstract ORCID
38.91 5
30 Consistency in rates of diagnosis of embryonic mosaicism, se… (10.1016/j.xfre.2020.05.005)
Abstract ORCID
38.91 5
31 Juvenile cystic adenomyoma, a rare diagnostic challenge: Cas… (10.1016/j.xfre.2021.02.002)
Abstract ORCID
38.91 5
32 Blastocyst score, a blastocyst quality ranking tool, is a pr… (10.1016/j.xfre.2020.05.004)
Abstract
36.18 27
33 GnRH agonists in the treatment of symptomatic endometriosis:… (10.1016/j.xfre.2022.11.009)
Abstract
35.37 25
34 Noyes, Hertig, and Rock revisited (10.1016/j.xfre.2020.04.004)
Abstract ORCID
34.95 4
35 Tobacco consumption is associated with slow-growing day-6 bl… (10.1016/j.xfre.2020.04.006)
Abstract ORCID
34.95 4
36 Time to blastulation is superior to individual components of… (10.1016/j.xfre.2020.09.016)
Abstract ORCID
34.95 4
37 Increased male live-birth rates after blastocyst-stage froze… (10.1016/j.xfre.2021.02.008)
Abstract ORCID
34.95 4
38 Association of bioavailable inhibin B and oocyte yield in co… (10.1016/j.xfre.2021.03.005)
Abstract ORCID
34.95 4
39 Birthweight associations with parental obesity: retrospectiv… (10.1016/j.xfre.2021.04.011)
Abstract ORCID
34.95 4
40 Eliminating health inequities in reproductive medicine: ensu… (10.1016/j.xfre.2022.04.002)
Abstract ORCID
34.95 4
41 Transvaginal radiofrequency ablation: a therapeutic option f… (10.1016/j.xfre.2024.07.001)
Abstract ORCID
34.95 4
42 Endocrine disruptors and female fertility: a review of pesti… (10.1016/j.xfre.2022.04.003)
Abstract
34.04 22
43 Fertility preservation in a transgender man without prolonge… (10.1016/j.xfre.2020.03.003)
Abstract
33.06 20
44 The contribution of racism-related stress and adversity to d… (10.1016/j.xfre.2021.10.003)
Abstract
31.97 18
45 Fertility preservation in transgender men without discontinu… (10.1016/j.xfre.2022.02.002)
Abstract
31.38 17
46 The effect of estrogen therapy on spermatogenesis in transge… (10.1016/j.xfre.2021.06.002)
Abstract
30.76 16
47 So near yet so far away (10.1016/j.xfre.2020.09.013)
Abstract ORCID
30.10 3
48 Elevated activity levels of activating autoantibodies to the… (10.1016/j.xfre.2020.09.015)
Abstract ORCID
30.10 3
49 Schistosoma haematobium ova in human semen: a case report (10.1016/j.xfre.2020.10.004)
Abstract ORCID
30.10 3
50 Fused blastocysts as a consequence of group embryo culture:… (10.1016/j.xfre.2020.10.010)
Abstract ORCID
30.10 3